Jersey Woman Highlights Impact of Gene Research on Her Cancer Treatment

A woman from Jersey has expressed commendation for cancer research, stating it has significantly impacted her life. Margi Clarke possesses the faulty BRCA gene, which elevates the probability of developing specific types of cancer. Upon the gene’s discovery, she was offered annual screenings, which were crucial in detecting a minute cancerous growth in 2019, leading to the effective treatment of her cancer. Ms. Clarke has joined a campaign initiated by Cancer Research UK, advocating for increased funding to investigate how genes contribute to cancer development and to identify effective prevention and treatment methods. In 2016, Ms. Clarke and her mother, Ginny Clarke, both underwent genetic testing due to a family history of cancer. Ms. Clarke’s mother had received a breast cancer diagnosis three times over a 20-year period. The tests confirmed that both individuals carried the mutated BRCA 2 gene, and both were subsequently offered counselling. Ms. Clarke remarked that she was “very lucky and fortunate” and that “being able to have those tests was really helpful in picking up my cancer”. Ms. Clarke now has a daughter, who faces a 50% chance of inheriting the faulty gene from her mother. Ms. Clarke stated: “Hopefully, with all of the donations to Cancer Research UK, she’ll have a very different experience to us and hopefully medical science will have moved on so her experience will be much better even if she has inherited the mutation.” Ms. Clarke has also praised her daughter for her efforts in raising awareness about the BRCA genes. She further added: “It’s nice to let other people know that you can do something about it because you can be vigilant, and you can try and prevent it, so that 30 years later you can still be here, like me.” Dr. Hugo De La Peña, a breast cancer consultant at University Hospital Southampton, regularly provides support to Jersey patients referred there for treatment. He commented: “We definitely need help from central governments,” and suggested that “different teams could compete for it” because “the more competition there is, the better it is for everyone”. Dr. Hugo further noted: “We cure cancer almost every single day but that’s not good enough, we need to cure cancer every single day and more research is the key to achieving that.” Researchers have determined that approximately 70% of women with faulty BRCA1 or BRCA2 genes will develop breast cancer by the age of 80. To stay informed by BBC Jersey, follow them on X (formerly Twitter) and Facebook. Submissions for story ideas can be sent to channel.islands@bbc.co.uk. Copyright 2024 BBC. All rights reserved. The BBC is not responsible for the content of external sites. Read about our approach to external linking.